Bvf Inc Eledon Pharmaceuticals, Inc. Transaction History

Bvf Inc

$3.34 Billion
Q1 2024

A detailed history of Bvf Inc transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 4,326,710 shares of ELDN stock, worth $10.3 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

4,326,710

Previous 4,326,710 -0.0%

Holding current value

$10.3 Million

Previous $7.79 Million 14.45%

% of portfolio

0.27%

Previous 0.2%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.34 - $2.85 $2.68 Million - $5.7 Million	2,000,000 Added 85.96%	4,326,710 $5.93 Million
Q1 2022 May 16, 2022	BUY	$3.06 - $4.89 $2.9 Million - $4.64 Million	948,690 Added 68.84%	2,326,710 $9.17 Million
Q4 2021 Feb 14, 2022	BUY	$4.02 - $6.07 $58,631 - $88,530	14,585 Added 1.07%	1,378,020 $6.08 Million
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.46 $1.49 Million - $2.12 Million	250,000 Added 22.45%	1,363,435 $8.43 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $19.22 $11 Million - $21.4 Million	1,113,435 New	1,113,435 $11.9 Million

Others Institutions Holding ELDN

# of Institutions

Shares Held

9.61M

Call Options Held

500

Put Options Held

1.4K

View Full List

About Eledon Pharmaceuticals, Inc.

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $32.7M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

More about ELDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account